Virus vs. host: Exposing an evolutionary arms race
Scientists have solved a 40-year old mystery and shed light on an evolutionary arms race played out between cytomegalovirus (CMV) and the immune system. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 10, 2017 Category: Science Source Type: news

The Boston Marathon: Brave and beyond
Brave. It’s the word inscribed on the simple band Mary Tremper wears on her left wrist. The band is a reminder from her son Shane that she possesses the strength and courage to bravely face the future. When Mary, a Boston Children’s Hospital Miles for Miracles runner, found the band in the hospital gift shop she knew it was from Shane. And as Mary has shared her son’s story with her teammates and listened to theirs, they have redefined brave, together. A few of their stories, including the Tremper’s, follow. Brave: Remembering Shane Shane in the Boston Children’s NICU. “I run for Shane. I run because he...
Source: Thrive, Children's Hospital Boston - April 10, 2017 Category: Pediatrics Authors: Lisa Fratt Tags: Our Patients’ Stories Liver transplant NICU RSV Source Type: news

Virus vs. host -- New research exposes an evolutionary arms race
(Monash University) Imaging CoE scientists have solved a 40-year old mystery and shed light on an evolutionary arms race played out between cytomegalovirus (CMV) and the immune system. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 9, 2017 Category: Infectious Diseases Source Type: news

What Causes Uveitis?
Discussion Inflammation of the middle layer of the eye, or uvea, is termed uveitis. Uveitis can be divided into anterior, intermediate or posterior uveitis by involving the anterior (iris and ciliary body), intermediate (vitreous) or posterior (choroid and usually retina) compartments. Panuveitis involves all 3 compartments. Duration can also be used to classify uveitis. Acute is 6 weeks and > 3 months is chronic persistent uveitis. Episodic periods of inactivity and reactivity that last more than 3 months are called recurrent uveitis. A third way to characterize uveitis is if it is granulomatous or not. Uveitis increas...
Source: PediatricEducation.org - April 3, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations Officer
SOUTH SAN FRANCISCO, Calif., April 03, 2017 -- (Healthcare Sales & Marketing Network) -- Atara Biotherapeutics, Inc. (ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been u... Biopharmaceuticals, Personnel Atara Biotherapeutics, Epstein-Barr Virus, Cytomegalovirus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 3, 2017 Category: Pharmaceuticals Source Type: news

Study Casts Doubt on a Brain Cancer ’ s Link to Herpes
Researchers find no evidence of cytomegalovirus in tumor tissue (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 7, 2017 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Infections, Neurology, Oncology, News, Source Type: news

Study Casts Doubt on A Brain Cancer's Link to Herpes
Researchers find no evidence of cytomegalovirus in tumor tissue Source: HealthDay Related MedlinePlus Pages: Brain Tumors, Cytomegalovirus Infections (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 7, 2017 Category: Consumer Health News Source Type: news

Study Casts Doubt on a Brain Cancer ’ s Link to Herpes
Researchers find no evidence of cytomegalovirus in tumor tissue (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 6, 2017 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Infections, Neurology, Oncology, News, Source Type: news

Study finds no evidence of common herpes type virus in aggressive brain cancer tissue
(Johns Hopkins Medicine) In a rigorous study of tumor tissue collected from 125 patients with aggressive brain cancers, researchers at Johns Hopkins say they have found no evidence of cytomegalovirus (CMV) infection and conclude that a link between the two diseases, as claimed by earlier reports, likely does not exist. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 28, 2017 Category: Cancer & Oncology Source Type: news

Merck ’s letermovir meets primary endpoint in Phase III trial to prevent CMV infection
Healthcare firm Merck has reported positive results from the Phase III clinical trial of anti-viral drug letermovir to prevent cytomegalovirus (CMV) infection in recipients of bone marrow transplant. (Source: Drug Development Technology)
Source: Drug Development Technology - February 28, 2017 Category: Pharmaceuticals Source Type: news

Merck ’s Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) Infection in Bone Marrow Transplant Recipients, Highly Effective Through Week 24 Post-Transplant in Pivotal Phase 3 Study
Dateline City: KENILWORTH, N.J. Letermovir Prophylaxis Associated with Lower All-Cause Mortality Through Week 24 Post-Transplant Company Plans to Submit New Drug Applications for Letermovir in U.S. and EU in 2017KENILWORTH, N.J.--(BUSINESS WIRE)--Merck& Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, today announced results of the pivotal Phase 3 clinical study of letermovir, an investigational antiviral medicine for the prevention of clinically-significant cytomegalovirus (CMV) infection in adult (18 years and older) CMV-seropositive recipients of an allogenei...
Source: Merck.com - Research and Development News - February 26, 2017 Category: Pharmaceuticals Tags: Research and Development News Corporate News Latest News #Merck #MRK $MRK Letermovir MSD NYSE:MRK Source Type: news

New antiviral drug cuts cytomegalovirus infection, improves survival in patients undergoing donor stem cell transplant
In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial has shown that a novel agent can protect against the most common viral infection that patients face after transplantation. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 24, 2017 Category: Science Source Type: news

Ties: My Daughter ’ s Silent Virus: Congenital CMV
To protect your baby from a disabling disease, first you have to know that it exists. (Source: NYT Health)
Source: NYT Health - February 24, 2017 Category: Consumer Health News Authors: MEGAN NIX Tags: Cytomegalovirus Pregnancy and Childbirth Ears and Hearing Deafness Disabilities Cochlear Implants Families and Family Life Source Type: news

Link between herpes in pregnancy and autism is unconfirmed
Conclusion This was a Norwegian case-control study that looked at whether maternal infections during pregnancy are associated with the risk of neurological developmental disorders such as autism spectrum disorders (ASDs) in their children. The study initially found no association between any of the pathogens during pregnancy or after delivery, and the development of ASD in boys or girls. Further investigations suggested that high levels of HSV-2 virus antibodies during mid-pregnancy were associated with increased risk of the development of ASD in boys. The researchers suggest that the suspected risk of ASD associated wit...
Source: NHS News Feed - February 24, 2017 Category: Consumer Health News Tags: Pregnancy/child Neurology Mental health Source Type: news

New antiviral drug cuts cytomegalovirus infection and improves survival in patients
(Dana-Farber Cancer Institute) In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute has shown that a novel agent can protect against the most common viral infection that patients face after transplantation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 24, 2017 Category: Global & Universal Source Type: news